Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.

Ann Oncol

Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.

Published: September 2015

Download full-text PDF

Source
http://dx.doi.org/10.1093/annonc/mdv306DOI Listing

Publication Analysis

Top Keywords

treatment dyspnoea
4
dyspnoea advanced
4
advanced cancer
4
cancer patients
4
patients esmo
4
esmo clinical
4
clinical practice
4
practice guidelines
4
treatment
1
advanced
1

Similar Publications

Background: Chronic obstructive pulmonary disease (COPD) primarily originates from exposure to tobacco smoke, although factors, such as air pollution and exposure to chemicals, also play a role. One of the primary treatments for COPD is oxygen therapy, which helps manage dyspnea and improve survival rates. Mobile health (mHealth) technologies have demonstrated significant potential in monitoring patients with chronic diseases, offering new avenues for enhancing patient care and disease management.

View Article and Find Full Text PDF

Type I and mixed cryoglobulinemic vasculitis differ in pathophysiology, clinical presentation, and therapeutic response. We report a case of refractory cryoglobulinemic vasculitis diagnosed following ischemic non-obstructive coronary artery disease (INOCA). The patient presented with dyspnea, as well as abdominal pain due to ischemic enteritis, purpura, and renal failure requiring dialysis.

View Article and Find Full Text PDF

We report the case of a 73-year-old man with progressive dyspnea and acute respiratory failure. Imaging revealed extensive infiltrative shadows in the right lung. A bronchoscopic biopsy confirmed primary lung adenocarcinoma harboring the BRAF V600E mutation.

View Article and Find Full Text PDF

Introduction: Physical inactivity due to shortness of breath is common among patients with uncontrolled asthma. We evaluated the body mass composition and exercise capacity of patients with poorly controlled asthma, despite maximal inhalation therapy.

Methods:  We recruited 56 patients from the Asthma Clinic of the University Hospital of Liège between September 2020 and December 2023, and 14 healthy subjects.

View Article and Find Full Text PDF

This is a novel case of idiopathic chylopericardium and chylothorax in a young male who had no significant medical history. He first presented with dyspnea due to idiopathic chylopericardium, which was refractory to medical and surgical treatments, including a medium-chain triglyceride diet, octreotide, and video-assisted pericardial window. The chylopericardium persisted and progressed to concomitant left-sided chylothorax.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!